Who Are Kate Danson and Dr. Mitchell Franklin
Kate Danson is a corporate director and governance professional with public board seats across major listed companies. Dr. Mitchell Franklin is a finance and accounting academic whose work on auditing, disclosure, and regulation is cited in SEC filings and policy discussions. Both figures are referenced in public corporate governance documents and financial databases.
Public records show Danson serving on audit and compensation committees, while Franklin has advised regulators and testified on accounting standards. Their profiles appear in SEC director disclosures, proxy statements, and university faculty listings. For background on corporate director requirements, see the SEC's overview of board composition U.S. Securities and Exchange Commission.
Companies, Committees, and Governance Roles
Danson has held board positions at large-cap public companies, where she participates in governance, risk, and audit oversight. Her committee assignments are disclosed in annual proxy statements filed with the SEC, including votes on director compensation and audit committee charters.
Dr. Mitchell Franklin has served on academic advisory panels linked to accounting standard-setters and has published research on financial reporting quality. His work is referenced in studies on audit committee effectiveness and internal controls, which are key topics in corporate governance disclosures Forbes.
Public Data, Rankings, and Source References
Director and officer data for both individuals can be traced through SEC EDGAR filings, board member databases, and institutional proxy advisors. These sources list committee roles, tenure dates, and independence determinations for public company boards.
Academic profiles for Dr. Mitchell Franklin are available through university websites and research repositories that index finance and accounting publications. Public company filings and governance ratings platforms also reference Danson's board service Tesla and SpaceX as examples of companies with detailed director disclosures.
